The Lancet Oncology
Издатель: Elsevier · ISSN 1470-2045 · 93 статей
- Cancer and the microbiome: from association to intervention
- Not all thoracic micronodules are metastases
- US EPA research and oversight on carcinogens are in disarray, critics contend
- Pazopanib alternating with bevacizumab in patients with metastatic clear-cell renal cell carcinoma naive to treatment: a multicentre, single-arm, phase 1/2 trial
- Neoadjuvant nivolumab plus ipilimumab in surgically resectable hepatocellular carcinoma (PRIME-HCC): a prospective, phase 1b, single-arm trial and translational analyses
- Can immunotherapy reshape resectable hepatocellular carcinoma?
- Talazoparib plus enzalutamide versus placebo plus enzalutamide in metastatic androgen pathway modulator-resistant (castration-resistant) prostate cancer (TALAPRO-2): a biomarker analysis of circulating tumour DNA and cells for prognosis and molecular profiling
- 2026 ESMO Congress
- India caps price of 137 cancer drugs
- WHO releases framework for expanding access to early breast cancer care
- Brazil improves access to cancer screening and care
- Sweating the details in exercise oncology
- Iberdomide for minimal residual disease-negative myeloma—from underdog to the spotlight
- Time to say goodbye to full-field digital mammography in population-based screening?
- Comprehensiveness of national cancer control plans
- The unfulfilled promise of effective cancer medicines priced beyond reach
- Rare earth elements and the fragile promise of cancer theranostics
- Why childhood cancer medicines need market shaping led by the Global Platform: toward market transformation
- From biomarker actionability to surveillance utility in SERENA-6
- BCG-unresponsive non-muscle-invasive bladder cancer
- BCG-unresponsive non-muscle-invasive bladder cancer – Authors’ reply
- 70th IAEA General Conference
- India reaches 8 million milestone in HPV campaign
- US EPA repeals emission limits
- Could Brazil's tuberculosis network detect lung cancer earlier?
- New UK National Cancer Board
- Viet Nam considers health insurance for cancer screening
- 2026 ASTRO Annual Meeting
- Impact of the Trump Administration on the Affordable Care Act
- Europe has fallen behind in number of oncology trials